Intellia Therapeutics, Inc. - NTLA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | President and CEO | S | D | 2,785.0 | 13.0 | 36,205.0 | 1,147,064.0 | View | |
| Aug 24, 2026 | President and CEO | S | D | 19,890.0 | 12.6 | 250,614.0 | 1,149,849.0 | View | |
| Jul 24, 2026 | EVP, Chief Financial Officer | S | D | 8,111.0 | 11.25 | 91,248.75 | 148,175.0 | View | |
| Jul 06, 2026 | VP, Chief Accounting Officer | S | D | 2,641.0 | 16.78 | 44,315.98 | 66,886.0 | View | |
| Jul 06, 2026 | EVP, Chief Financial Officer | S | D | 4,677.0 | 18.0 | 84,186.0 | 156,286.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 35,148.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 41,083.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 33,559.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 32,609.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 216,653.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 143,893.0 | View | |
| Jun 10, 2026 | — | A | A | 13,300.0 | 0.0 | 0.0 | 13,300.0 | View | |
| Jun 10, 2026 | — | A | A | 9,200.0 | 0.0 | 0.0 | 36,403.0 | View |